LZB:NYSELa-Z-Boy Incorporated Analysis
Data as of 2026-05-19 - not real-time
$34.55
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
La‑Z‑Boy (LZB) trades at $34.55, well below its DCF‑derived fair value of $65.83, implying ~28% upside. The stock’s trailing P/E of 17.3 is modest for the consumer cyclical space and aligns with a value narrative. A dividend yield of 2.8% with a 45% payout ratio suggests sustainable income. Technicals show the 20‑day SMA ($35.24) just above price, while the 50‑day SMA ($33.94) sits below, indicating a neutral bias. The MACD histogram is negative and the signal line is bearish, hinting at short‑term pressure. RSI at 48 is neither overbought nor oversold, supporting a wait‑and‑see stance.
Volatility is elevated at 31.6% over the past 30 days, but beta near 0.94 suggests market‑level risk rather than excess. The price sits above the identified support of $33.48 and below resistance at $36.80, giving a modest technical cushion. Operating margins are thin (5.4%) yet cash flow remains healthy, with free cash flow exceeding $190 M. The recent sale of the American Drew and Kincaid casegoods businesses reduces exposure to lower‑margin wholesale segments. Management’s declaration of a quarterly dividend reinforces shareholder commitment. Combined, these fundamentals and valuation gaps support a buy recommendation across horizons.
Volatility is elevated at 31.6% over the past 30 days, but beta near 0.94 suggests market‑level risk rather than excess. The price sits above the identified support of $33.48 and below resistance at $36.80, giving a modest technical cushion. Operating margins are thin (5.4%) yet cash flow remains healthy, with free cash flow exceeding $190 M. The recent sale of the American Drew and Kincaid casegoods businesses reduces exposure to lower‑margin wholesale segments. Management’s declaration of a quarterly dividend reinforces shareholder commitment. Combined, these fundamentals and valuation gaps support a buy recommendation across horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bearish MACD signal
- Price near support level
- Sustainable dividend
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant DCF upside
- Improving cash flow after casegoods divestiture
- Attractive dividend yield
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term undervaluation relative to fair value
- Stable earnings and free cash flow generation
- Strategic focus on higher‑margin retail and e‑commerce
Key Metrics & Analysis
Financial Health
Revenue Growth3.80%
Profit Margin3.93%
P/E Ratio17.3
ROE8.09%
ROA4.31%
Debt/Equity53.88
P/B Ratio1.4
Op. Cash Flow$237.7M
Free Cash Flow$194.7M
Technical Analysis
TrendNeutral
RSI48.2
Support$33.48
Resistance$36.80
MA 20$35.24
MA 50$33.94
MA 200$35.44
MACDBearish
VolumeStable
Fear & Greed Index89.61
Valuation
Fair Value$65.83
Target Price$44.50
Upside/Downside28.80%
GradeUndervalued
TypeValue
Dividend Yield2.80%
Risk Assessment
Beta0.94
Volatility31.65%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.